OPA1 and autosomal dominant optic atrophy: For example, Mfn2 deficiency causes Charcot–Marie–Tooth (CMT) disease type 2A in 20–40% of CMT cases [10,11], while OPA1 mutations cause dominant optic atrophy (DOA) [12].